Alterity Therapeutics Limited (ATHE)
NASDAQ: ATHE · Real-Time Price · USD
4.920
+0.100 (2.07%)
Jun 29, 2026, 1:38 PM EDT - Market open

Alterity Therapeutics Stock Forecast

Stock Price Forecast

The 2 analysts with 12-month price forecasts for Alterity Therapeutics stock have an average target of 11, with a low estimate of 10 and a high estimate of 12. The average target predicts an increase of 123.58% from the current stock price of 4.92.

Analyst Consensus: Buy
Target Low Average Median High
Price $10 $11 $12 $12
Change +103.25% +123.58% +143.90% +143.90%

Analyst Ratings

The average analyst rating for Alterity Therapeutics stock from 2 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Sep '25Oct '25Feb '26Apr '26May '26Jun '26
Strong Buy 101001
Buy 111111
Hold 000000
Sell 000000
Strong Sell 000000
Total 212112

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Unknown Analyst
Ladenburg Thalmann & Co.
No rating
Ladenburg Thalmann & Co.
Buy
Initiates
$10
Buy Initiates $10 +103.25% Jun 16, 2026
Maxim Group
Maxim Group
Buy
Reiterates
$12
Buy Reiterates $12 +143.90% Jun 10, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
3.53M
from 5.44M
Decreased by -35.11%
Revenue Next Year
1.65M
from 3.53M
Decreased by -53.27%
EPS This Year
-2.58
EPS Next Year
-2.58
from -2.58
Fiscal Year FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027
Period Ending Jun 30, 2021 Jun 30, 2022 Jun 30, 2023 Jun 30, 2024 Jun 30, 2025 Jun 30, 2026 Jun 30, 2027
Revenue
4.34M5.12M3.92M4.02M5.44M3.53M1.65M
Revenue Growth
-18.06%-23.56%2.63%35.32%-35.11%-53.27%
EPS
-0.45-0.27-0.28-0.26-0.09-2.58-2.58
EPS Growth
-------
Forward PE
-------
No. Analysts -----33
Financial currency is AUD. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 202620272028
High 5.8M 4.9M
Avg 3.5M 1.6M
Low n/a n/a

Revenue Growth

Revenue Growth 202620272028
High
6.4%
40.2%
Avg
-35.1%
-53.3%
Low
-100.0%
-100.0%

EPS Forecast

EPS 202620272028
High - -
Avg -2.58 -2.58
Low -5.15 -5.15

EPS Growth

EPS Growth 20272028
High - -
Avg - -
Low - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.